Latest News
CAD Not Responsive to Some Measures Used in Warm Hemolytic Anemia
Autoimmune Hemolytic Anemia Linked With High Mortality in the ICU
Rare Disease Patients and Advocate to Headline NORD Conference in October
The First Report of an HbE Heterozygous Patient With CAD and COVID-19 Infection
High Cold Agglutinin Titers Reported in Two COVID-19 Case Reports
Patients With CAD Report Pervasive Fatigue, Worsening Symptoms
Researchers Discover Potential Link Between COVID-19 and CAD
COVID-19 Vaccination Linked With Detection of CAD
Cell, Gene Therapy Breakthroughs Outpacing Healthcare System, Experts Say
Reconsidering the Role of Disease Biomarkers in Drug Development
Factor D Inhibition Shows Therapeutic Potential in CAD
Researchers Suggest Rituximab-Based Therapy for CAD
COVID-19 Associated With AIHA: A Case Report
HLC Assay More Effective in Detecting CAD Monoclonal Components
CAD Clinical Trials
An error has occurred, which probably means the feed is down. Try again later.
CAD Insights
Managing Cold Agglutinin Disease and Other Hemolytic Anemias
Corticosteroids are a first-line therapy for warm autoimmune hemolytic anemia, but may be less effective in patients with cold autoimmune hemolytic anemia.
The Power of Inhibiting the Complement System in Cold Agglutinin Disease
The inhibition of the complement system in cold agglutinin disease has been shown to result in impressive clinical recovery.
Advancing Our Knowledge of Cold Agglutinin Disease and Its Treatments
Because cold agglutinin disease (CAD) is a rare subset of another rare disease, very few medical researchers devote entire studies to exploring it.
The Far-Reaching Impact of Innovative Clinical Trial Designs in Rare Disease
We examine the lasting impact of innovative clinical trial designs for rare diseases on other clinical experiments.
Patient Perspectives
Managing CAD: My Struggles to Make Exercise a Priority
When I was first diagnosed with cold agglutinin disease (CAD), my symptoms were at an all-time high.
The Role of Home Hemoglobin Test Kits for CAD Patients
Having an autoimmune disease such as cold agglutinin disease (CAD) means you see your hematologist often.
Cold Agglutinin Disease Patients Should Pay Attention to Their Nails
I have CAD and I am learning how to pay attention to the more subtle signs of the disease’s progression.
CAD Features
‘Fundamental Flaws’ Plague Drug Development Process, Ultragenyx CEO Dr. Emil Kakkis Says
Ultragenyx CEO Dr. Emil D. Kakkis said federal regulators should focus more on biomarkers and less on clinical endpoints when it comes to drug approvals.
Florida Fiber Artist Advocates for Fellow Cold Agglutinin Disease Patients
Abstract artist Betty Usdan-Zwickler, 83, of Boca Raton, Florida, is also a fierce advocate for fellow patients with cold agglutinin disease (CAD).
CAD Foundation Strives to Increase Knowledge of Rare Autoimmune Hemolytic Anemia
The all-volunteer CAD Foundation fights for patients with a rare anemia that has no approved therapy. Three companies are conducting clinical trials.
Updates on the Treatment of Cold Agglutinin Disease
Given the rarity of CAD and lack of comparative trials, treatment plans are primarily based on findings from nonrandomized trials and clinical experience.
Rare Care Podcast
- Loading...
Loading...
Loading... 
Loading...